id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1875550,cbc0dff1-e931-4125-a78f-e2f7cc7ed9f2,Q3,"ARNALL GOLDEN GREGORY, LLP",400713137,PHARMA AND BIOPHARMA OUTSOURCING ASSOCIATION,2016,third_quarter,MED,FDA oversight issues of generic drugs; issues regarding generic drug user fees; 21st Century CURES Act; Innovation for Healthier Americans Act,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2016-10-12T14:00:01.390000-04:00